£6.0M
Apposite Capital has led a £6m Series A round in Mirada Medical to accelerate the development of artificial intelligence for cancer care.
Mirada Medical
Mirada Medical develops artificial intelligence software for cancer treatment planning.
£6.0MTotal raised
Mirada Medical develops medical imaging software and artificial intelligence applications to assist clinicians with cancer treatment planning. The firm builds tools that simplify complex image processing tasks for hospitals and health centres globally.
Categories
Team
HB
Hugh Bettesworth
CEO
Mark Gooding
CTO
Mark brings scientific and research experience from his time at Mirada Medical, Inpictura Ltd, and The University of Manchester.
LinkedIn
Annamaria Albano
Annamaria brings marketing and corporate communications experience across medical devices, healthcare, and B2B organisations. She previously held marketing roles at Lynton Lasers Group, Mirada Medical, and Ramsay Health Care.
LinkedIn